Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.57 |
| ▸ | MAOB | P27338 | 2/20 | 0.57 |
| ▸ | ACHE | P22303 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | AR | P10275 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | GLA | P06280 | 3/20 | 0.54 |
| ▸ | GAA | P10253 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30593559 | 1.00 | MAOA (0.57) | MAOAMAOBACHEKMT2AMEN1 | |
| SCHEMBL6591353 | 0.84 | MAOB (0.70) | MAOAMAOBACHEKMT2AMEN1 | |
| SCHEMBL9204774 | 0.83 | KMT2A (0.66) | MAOAMAOBKMT2AMEN1AR | |
| SCHEMBL29677221 | 0.83 | KMT2A (0.66) | MAOAMAOBKMT2AMEN1AR | |
| SCHEMBL6589340 | 0.82 | MAOB (0.68) | MAOAMAOBACHEKMT2AMEN1 | |
| SCHEMBL17640870 | 0.82 | CA12 (0.66) | MAOAMAOBKDM4EALDH1A1HPGD | |
| SCHEMBL29270309 | 0.82 | MAOA (0.65) | MAOAMAOBKMT2AMEN1AR | |
| SCHEMBL29270300 | 0.80 | KMT2A (0.59) | MAOAMAOBKMT2AMEN1AR | |
| SCHEMBL23502938 | 0.80 | AR (0.50) | MAOAMAOBACHEKMT2AMEN1 | |
| SCHEMBL12617606 | 0.79 | MAOB (0.67) | MAOAMAOBACHEKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023205317-A1 | POLYMER COACERAVATES AND METHODS OF DISRUPTING AND REMOVING BIOFILMS | THE UNIVERSITY OF AKRON (US) | 2023-10-26 | — | — | WO | disclosed |
| US-11033573-B1 | Non-ionic coacervates for dry, humid and wet adhesion | THE UNIVERSITY OF AKRON (US) | 2021-06-15 | — | — | US | disclosed |
| US-20170298183-A1 | VEGETABLE OIL BASED VISCOELASTIC POLYMERS THAT DISPLAY PHOTORESPONSIVE RHEOLOGICAL AND ADHESIVE PROPERTIES | THE UNIVERSITY OF AKRON | 2017-10-19 | — | — | US | disclosed |
| US-20170298183-A1 | VEGETABLE OIL BASED VISCOELASTIC POLYMERS THAT DISPLAY PHOTORESPONSIVE RHEOLOGICAL AND ADHESIVE PROPERTIES | THE UNIVERSITY OF AKRON | 2017-10-19 | — | — | US | disclosed |
| WO-2016049029-A1 | VEGETABLE OIL BASED VISCOELASTIC POLYMERS THAT DISPLAY PHOTORESPONSIVE RHEOLOGICAL AND ADHESIVE PROPERTIES | THE UNIVERSITY OF AKRON (US) | 2016-03-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11033573-B1 | Non-ionic coacervates for dry, humid and wet adhesion | NCAPH, ICAM1, EPCAM | MAOA 4278/4885MAOB 4605/4885ACHE 3470/4885 |
| US-20170298183-A1 | VEGETABLE OIL BASED VISCOELASTIC POLYMERS THAT DISPLAY PHOTORESPONSIVE RHEOLOGICAL AND ADHESIVE PROPERTIES | HTR3D, FADS1, SCD | MAOA 2050/4885MAOB 2485/4885ACHE 2847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.